| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 05/17/2001 | WO2001034606A1 Pharmaceutically active isoindoline derivatives |
| 05/17/2001 | WO2001034603A2 Bicyclic and tricyclic heteroaromatic compounds |
| 05/17/2001 | WO2001034602A2 Process and intermediates for the preparation of imidazolidinone alpha v integrin antagonists |
| 05/17/2001 | WO2001034601A2 Imidazopyridine derivatives as phosphodiesterase vii inhibitors |
| 05/17/2001 | WO2001034573A1 Compounds |
| 05/17/2001 | WO2001034567A1 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa |
| 05/17/2001 | WO2001034127A1 Prevention of plaque rupture by acat inhibitors |
| 05/17/2001 | WO2001014358A3 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 05/17/2001 | WO2001002404A3 Method for producing triethylene diamine, using ethylene diamine |
| 05/17/2001 | CA2390163A1 Dye labeled imidazoquinoline compounds |
| 05/17/2001 | CA2389999A1 Process and intermediates for the preparation of imidazolidinone alpha v integrin antagonists |
| 05/17/2001 | CA2388729A1 Imidazopyridine derivatives as phosphodiesterase vii inhibitors |
| 05/17/2001 | CA2388593A1 Bicyclic and tricyclic heteroaromatic compounds |
| 05/17/2001 | CA2382676A1 Prevention of plaque rupture by acat inhibitors |
| 05/16/2001 | EP1099744A2 Organic electroluminescent device |
| 05/16/2001 | EP1098897A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 05/16/2001 | EP1098896A1 5-bicycloindole compounds |
| 05/16/2001 | EP1098894A1 Fkbp inhibitors |
| 05/16/2001 | EP1098883A1 Process for preparing heterocyclic compounds |
| 05/16/2001 | EP1098870A2 Nitric esters and nitrate salts of specific drugs |
| 05/16/2001 | EP1098650A1 Benzoquinolizidine and benzoindolizidine derivatives and therapeutic uses thereof |
| 05/16/2001 | CN1295573A Pharmaceutically available protoberberine salt derivatives, and protoberberine derivatives and salt thereof |
| 05/16/2001 | CN1295570A N-pyriconyl herbicides |
| 05/16/2001 | CN1295479A Beta 2-adrenergic receptor agonist |
| 05/16/2001 | CN1295072A New polycyclic system compound as neurotransmitter release reinforcer in treatment of identification fault and derivatives thereof |
| 05/16/2001 | CN1295071A Condensed imidezo-[1,2-a] pyridines |
| 05/15/2001 | US6232324 Use of pyrazolopyridine compound |
| 05/15/2001 | US6232322 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 05/15/2001 | US6232321 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 05/15/2001 | US6232313 Pyridazino quinoline compounds |
| 05/15/2001 | US6232308 Useful for inhibiting bone resorption, treating and preventing osteoporosis, inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, and angiogenesis |
| 05/15/2001 | US6231833 Administering to the mammal for treating serotonin system related disorders an effective amount of 2,7-substituted octahydro-1h-pyrido(1,2-a)pyrazine derivative as ligands for serotonin receptor |
| 05/10/2001 | WO2001032660A1 Compounds having 5-ht6 receptor antagonist activity |
| 05/10/2001 | WO2001032658A1 Polyazanaphthalene compound and medicinal use thereof |
| 05/10/2001 | WO2001032655A2 Quinoline and naphthyridine carboxylic acid antibacterials |
| 05/10/2001 | WO2001032649A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 05/10/2001 | WO2001032648A1 Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof |
| 05/10/2001 | WO2001032646A2 Sulfonamide derivatives |
| 05/10/2001 | WO2001032632A2 Pharmaceutically active 4-substituted pyrimidine derivatives |
| 05/10/2001 | WO2001032631A2 Heterocyclic cytotoxic agents |
| 05/10/2001 | WO2001032626A1 Isoquinoline and quinazoline derivatives having a combined 5ht1a, 5ht1b and 5ht1d receptor activity |
| 05/10/2001 | WO2001032615A1 1,4 substituted piperidinyl nmda/nr2b antagonists |
| 05/10/2001 | WO2001032604A1 Activators of soluble guanylate cyclase |
| 05/10/2001 | WO2001017959A3 Vitronectin receptor antagonists |
| 05/10/2001 | US20010001101 Anti-fibroproliferative agents, treatment of pulmonary fibrosis, renal fibrosis, cardiac fibrosis, arteriosclerosis or treating scar tissue formation following injury |
| 05/10/2001 | DE19953414A1 Imidazopyridinderivate als Phospodiesterase VII-Hemmer Imidazopyridine derivatives as phosphodiesterase VII inhibitor |
| 05/10/2001 | CA2389773A1 Activators of soluble guanylate cyclase |
| 05/10/2001 | CA2389312A1 Heterocyclic cytotoxic agents |
| 05/10/2001 | CA2389226A1 1,4 substituted piperidinyl nmda/nr2b antagonists |
| 05/10/2001 | CA2387613A1 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them |
| 05/09/2001 | EP1097980A2 Bathophenanthroline compound and process for preparing same |
| 05/09/2001 | EP1097934A1 Lk6-a derivatives |
| 05/09/2001 | EP1097926A1 Thiobenzimidazole derivatives |
| 05/09/2001 | EP1097719A1 NEP inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097718A1 NPY antagonists for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097707A1 Treatment of female sexual dysfunction |
| 05/09/2001 | EP1097706A1 Phosphodiesterase inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | CN1294590A Method of 3-substituted adenines via 2-thioxanthines |
| 05/09/2001 | CN1293896A Antifungal active compound compsns. |
| 05/09/2001 | CN1293893A Antifungal active compound compsns. |
| 05/08/2001 | US6229017 Process for preparing quinolone- and naphthyridone- carboxylic acids and esters thereof |
| 05/08/2001 | US6229016 Method for treating tumors using 2-aryl-naphthyridin-4-ones |
| 05/08/2001 | US6229015 Acridone derivatives and method of preparation of 8-hydroxy imidazoacridinone derivatives |
| 05/08/2001 | US6229014 8-azaspiro(4.5)decane-1-one; antidepressants and treatment of psycholigical disorders, specifically memory loss |
| 05/08/2001 | US6229011 N-aroylphenylalanine derivative VCAM-1 inhibitors |
| 05/08/2001 | US6228869 Ortho-sulfonamido bicyclic hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 05/08/2001 | US6228859 Antiasthmatic, antiinflammatory, antiallergen and antidepressant agents |
| 05/08/2001 | US6228553 Pyrrolo [1,2-A] pyrimidine compound and heat-sensitive recording material using the same |
| 05/08/2001 | CA2324484A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323464A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323191A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323183A1 Compounds for the treatment of female sexual dysfunction |
| 05/03/2001 | WO2001030781A2 INHIBITORS OF αLβ2 MEDIATED CELL ADHESION |
| 05/03/2001 | WO2001030780A2 Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| 05/03/2001 | WO2001030779A1 Naphthyridine derivatives |
| 05/03/2001 | WO2001030778A1 Thiazole and imidazo [4,5-b] pyridine compounds and their pharmaceutical use |
| 05/03/2001 | WO2001030753A2 Enhancement of production of camptothecins from plants |
| 05/03/2001 | WO2001030752A2 Indole compounds for treating bacterial infections |
| 05/03/2001 | DE19952147A1 Neue Cyclopropane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung New cyclopropanes, pharmaceutical compositions containing them and methods for their preparation |
| 05/03/2001 | CA2389034A1 Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| 05/03/2001 | CA2385178A1 Naphthyridine derivative |
| 05/02/2001 | EP1095031A1 Antiviral macrocyclic compounds |
| 05/02/2001 | EP1095025A2 Benzimidazoles, production thereof and use thereof as medicaments |
| 05/02/2001 | EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 05/02/2001 | EP1094816A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 05/02/2001 | EP1094806A2 Vasculoprotector |
| 05/02/2001 | CN1293674A Triazolo gerivatives and chemokine inhibitors containing the same as the active ingredient |
| 05/02/2001 | CN1293655A Bicyclo [2.2.1] heptanes and related compounds |
| 05/02/2001 | CN1293195A New polycyclicazaindole compound, its preparation method are medicine composition containing same |
| 05/02/2001 | CN1293194A New 7-amino pyrido[2,3-d] pyrimidine derivative |
| 05/02/2001 | CN1065244C Tricyclic benzazepine vasopressin antagonists |
| 05/02/2001 | CN1065243C Naphthyridine derivative |
| 05/01/2001 | US6225465 Process for the aminocarbonylation of benzazepines and benzodiazepines |
| 05/01/2001 | US6225323 Activated iododerivatives for the treatment of cancer and AIDS |
| 05/01/2001 | US6225322 4-(6,11-dihydro-5h-cyclohepta(2,1-b:4, 5-b')dipyridin-11-yl)-1-piperidinecarboxylic or sulfonic acid derivatives |
| 05/01/2001 | US6225315 Administering a cgmp pde inhibitor. |
| 05/01/2001 | CA2022576C Process for the preparation of castanospermine esters |
| 05/01/2001 | CA2016664C Indole derivative and method of production thereof |
| 04/26/2001 | WO2001029050A2 Condensed pyrrole derivatives as neuraminidase inhibitors |
| 04/26/2001 | WO2001029044A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |